Trial Profile
Desensitization With Bortezomib Before a Living Kidney Donation
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 10 Sep 2018
Price :
$35
*
At a glance
- Drugs Bortezomib (Primary)
- Indications Renal transplant rejection
- Focus Pharmacodynamics
- Acronyms VELDON
- 28 Sep 2016 Planned End Date changed from 1 Jul 2016 to 1 Mar 2018.
- 28 Sep 2016 Planned primary completion date changed from 1 Jul 2016 to 1 Mar 2017.
- 08 May 2013 New trial record